Obesity, diet, & lifestyle interventions

Browse the latest news, expert commentary, and educational content on obesity and lifestyle interventions.

Highlights

02-14-2023 | Obesity | News

Obesity as prevalent in type 1 diabetes as general US population

There is a “substantial” burden of overweight and obesity among people with type 1 diabetes, say US researchers who found rates to be in line with that of the general population.

11-01-2022 | SGLT2 inhibitors | News

Real-world adjunctive medication outcomes in type 1 diabetes revealed

People with type 1 diabetes who take GLP-1 receptor agonists or SGLT2 inhibitors in clinical practice have outcomes that are mostly – but not all – in line with those in controlled trials, say researchers.

10-10-2022 | Semaglutide | News

STEP 5: Sustained semaglutide treatment maintains weight loss

The substantial weight loss achieved with weekly semaglutide 2.4 mg is maintained if people continue to take the medication for 2 years, show the STEP 5 results.

Stay informed with Medicine Matters

Get the latest developments in diabetes delivered straight to your inbox

Medicine Matters Diabetes

Obesity, diet, & lifestyle interventions

Browse the latest news, expert commentary, and educational content on obesity and lifestyle interventions.

Highlights

Obesity as prevalent in type 1 diabetes as general US population

Real-world adjunctive medication outcomes in type 1 diabetes revealed

STEP 5: Sustained semaglutide treatment maintains weight loss

Semaglutide for weight loss: The STEP and SELECT trials

More on obesity & lifestyle interventions

Caloric restriction outperforms liraglutide for weight loss in prediabetes

DiRECT extension shows potential for persistent type 2 diabetes remission

More exercise may be better for beta-cell function in type 2 diabetes

Time-restricted fasting improves postprandial glucose tolerance

DiRECT: Type 2 diabetes remission through weight management

Obesity as prevalent in type 1 diabetes as general US population

Healthy lifestyle wards off type 2 diabetes microvascular complications

Microbiome support improves type 2 diabetes outcomes

FDA approves high-dose semaglutide for adolescents with obesity

Global type 2 diabetes burden increasing in adolescents and young adults

Intermittent fasting feasible with insulin-treated type 2 diabetes

Low-carb, high-fat diet gives glycemic benefits in randomized trial

High-dose semaglutide reduces obesity-linked inflammatory marker

Stay informed with Medicine Matters